A Lu, M Miao, TR Schoeb, A Agarwal… - The American Journal of …, 2011 - Elsevier Transforming growth factor-β (TGF-β) is key in the pathogenesis of diabetic nephropathy. Thrombospondin 1 (TSP1) expression is increased in diabetes, and TSP1 regulates latent TGF-β activation in vitro and in diabetic animal models. Herein, we investigate the effect of blockade of TSP1- ... Related articles - All 4 versions
MC Thomas - Diabetes and the Kidney, 2011 - books.google.com Pathogenetic Mechanisms of Diabetic Nephropathy Lai KN, Tang SCW (eds): Diabetes and the Kidney. Contrib Nephrol. Basel, Karger, 2011, vol 170, pp 48–56 Pathogenesis and Progression of Proteinuria Merlin C. Thomas Baker IDI Heart and Diabetes Institute, Melbourne, Vic., ... Related articles - All 2 versions
G Viswanathan, H Tighiouart… - American Journal of …, 2011 - urologyaccess.org « PreviousNext »American Journal of Kidney Diseases Volume 57, Issue 4 , Page B102, April 2011. 341 Complications of Chronic Kidney Disease (CKD) by Level of Albuminuria and Proteinuria in the Irbesartan in Diabetic Nephropathy Trial (IDNT). Gautham Viswanathan*: ... Cached - All 2 versions
[PDF] from perruchenautomne.euM Tonelli, P Muntner, A Lloyd… - Annals of internal …, 2011 - Am Coll Physicians ... Using Proteinuria and Estimated Glomerular Filtration Rate to Classify Risk in Patients With Chronic Kidney Disease. A Cohort Study. ... Objective: To validate a 5-category system for risk stratification based on the combination of eGFR and proteinuria. ... Cited by 9 - Related articles - All 6 versions
D Preiss, N Sattar… - American Heart Journal, 2011 - Elsevier Food and Drug Administration guidance now proposes that cardiovascular safety of new diabetes medicines be demonstrated. Consequently, trials should include a sufficient number of individuals with diabetes who are at high cardiovascular risk. We aimed to examine the impact of the ... Cited by 1 - Related articles - All 10 versions
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
安全保密
